Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $9.37, but opened at $9.00. Curaleaf shares last traded at $9.20, with a volume of 9,220 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Three research analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Down 1.7%

The business’s 50 day moving average is $7.27 and its 200-day moving average is $7.62. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The company has a market cap of $2.12 billion, a PE ratio of -23.26 and a beta of 1.51.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.51. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. The company had revenue of $324.23 million for the quarter, compared to the consensus estimate of $316.62 million. As a group, analysts predict that Curaleaf Holdings, Inc. will post -0.31 EPS for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.